The Influence of Induction Therapy on Graft and Patient Survival in Patients with and without Hepatitis C after Liver Transplantation
Authors:
Open Access
- 1 March 2010
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (3) , 590-601
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 studyLiver Transplantation, 2007
- Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicityClinical Transplantation, 2007
- Short-Term Induction Therapy with Anti-Thymocyte Globulin and Delayed Use of Calcineurin Inhibitors in Orthotopic Liver TransplantationLiver Transplantation, 2007
- Immunosuppression: Evolution in Practice and Trends, 1994–2004American Journal of Transplantation, 2006
- Induction with Rabbit Antithymocyte Globulin versus Induction with Corticosteroids in Liver Transplantation: Impact on Recurrent Hepatitis C Virus InfectionTransplantation, 2006
- The impact of thymoglobulin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplantA retrospective analysis of 298 consecutive patientsTransplantation Proceedings, 2004
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- Hepatitis C virus kinetics during and immediately after liver transplantationHepatology, 2002
- Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trialLiver Transplantation, 2002
- Anti-Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationLiver Transplantation, 2001